Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 studyPhilip A. Philip, Pascal Hammel, Muhammad Wasif Saif et al.|The Lancet. Gastroenterology & hepatology|2020Cited by 249
Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse modelsMei‐Juan Tu, Ai‐Ming Yu, Richard J. Bold et al.|Cancer Letters|2018Cited by 50
A randomized controlled trial assessing the effect of prescribed patient position changes during colonoscope withdrawal on adenoma detectionGeorge Ou, Jennifer J. Telford, Robert Enns et al.|Gastrointestinal Endoscopy|2014Cited by 43
Pneumatosis Intestinalis After Colonoscopy in a Crohn’s Disease Patient with Mucosal HealingNancy Fu, Brian Bressler, Edward Kim|Inflammatory Bowel Diseases|2011Cited by 15
Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumorsThomas J. Semrad, Karen Kelly, Edward Kim et al.|Cancer Chemotherapy and Pharmacology|2021Cited by 12